Hospital Combats Infections with Purchase of Germ-eliminating Robots
High Point Regional invests in Tru-D after participating in CDC-funded clinical trial
HIGH POINT, N.C. –Â After participating in the CDC-funded, large-scale, multi-hospital study, Benefits of Enhanced Terminal Room Disinfection (BETR-D), High Point Regional has invested in the very product validated in the landmark study. Adding to its already strict infection prevention protocols, High Point Regional purchased three Tru-D SmartUVC robots in an effort to reinforce its commitment to patient and staff safety.
A private, not-for-profit healthcare system owned by UNC Health Care, High Point Regional has consistently been on the leading edge of technology. With state-of-the-art facilities catering to more than 120,000 patients annually, High Point's goal is to get and keep its patients well. Tru-D will provide an additional level of security and comfort for bringing this mission to life.
"High Point Regional's purchase and implementation of multiple Tru-D SmartUVC robots is a testament to the value proven in the BETR-D study," said Chuck Dunn, president and CEO of Tru-D SmartUVC. "We anticipate and look forward to other hospitals following High Point Regional's lead in bolstering patient and staff safety with the investment in Tru-D."
The purchase comes just months after results of the BETR-D study, the first randomized, clinical trial on UVC disinfection, were released. High Point Regional was one of nine hospitals that participated in the study, which determined enhanced terminal room disinfection strategies decreased the cumulative incidence of multidrug-resistant organisms by 10 to 30 percent. In the study, the largest decreases were seen when Tru-D was added to the standard cleaning strategy. Tru-D was selected as the only device used because of its patented technology that eliminates human error and ensures that a proper dose of UV light is distributed throughout the room.
Dubbed "The Triplets," High Point Regional is utilizing one Tru-D in the operating room area and one for intensive care units while the third device is being used as a floater, traveling wherever it is needed.
"This technology will prove to be an important added line of defense to protect the integrity of our environment," said Angelina Drews, Infection Prevention Manager at High Point Regional.
After a hospital staff member cleans a room using traditional methods, Tru-D is rolled in to "finish the job." The machine is turned on from outside the room using an iPad remote, which features iTru-D, an application that tracks infection control data and simultaneously uploads the information to the hospital's web portal. With patented Sensor360 technology, Tru-D instantly analyzes the unique makeup of the room, including shape, size and contents, and then floods the targeted space (including shadows) with the proper amount of germicidal energy. Tru-D spends the minimum time necessary to confidently eliminate infectious germs from contaminated surfaces before notifying the operator that disinfection is complete.
For more information, visit Tru-D.com.
About Tru-D SmartUVC
Tru-D SmartUVC is the only UV disinfection device backed by a CDC-funded, randomized clinical trial to show that it is capable of reducing the transmission of health care-associated infections by up to 30 percent. More Tru-Ds have been deployed to disinfect hospitals across the globe than all other competing look-alike offerings, fighting deadly pathogens such as C. diff, MRSA, CRE, VRE, MERS, Ebola and many more. An effective and innovative technology backed by sound science, Tru-D SmartUVC is on a mission to eradicate HAIs making hospitals safer places for patients and staff. For information and links to independent studies on Tru-D, visit Tru-D.com.
MEDIA RELEASE
Christin Yates
Tru-D Public Relations
901-774-5771
